< Back to latest news & events

Healthcare Scanner

UPC could open its doors in 2022

January 2022

With news that the Austrian parliament has ratified the Protocol on the provisional application of the Agreement on a Unified Patent Court on 2 December 2021, the Unified Patent Court (UPC) opening in 2022 is becoming more likely. This will be a significant change to the patent litigation landscape in Europe and will harmonise patent litigation across up to 24 EU Member States (MS). It will also mean that patentees can choose to validate a Unitary Patent (UP) that will cover all EU MS who have ratified the UPC Agreement (R-MS).

When Austria deposits its ratification of the Protocol this will trigger the provisional phase of the UPC. During the provisional phase, secondary legislation will be finalised, budgets set and Judges appointed before the UPC opens its doors. It is estimated that the provisional phase will take 8-10 months, following which Germany will deposit its ratification of the UPC Agreement (UPCA) triggering the launch of the UPC four months later. Based on current ratifications of the UPCA, on launch the UPC and UP will cover 17 EU MS, including Germany, France, Italy and The Netherlands.

The launch of the UPC will not alter the prosecution or opposition of EPs but at grant there will now be the opportunity to validate a new UP designation. Validating a UP will create a designation with unitary effect across all R-MS, which will sit alongside other national patents validated from the EP. The request for a UP must be made within one month of the date of grant and we expect that the EPO will offer a three-month Sunrise Period for validation of a UP before the UPC launch. The EP(UP) is subject to the exclusive jurisdiction of the UPC and cannot be opted-out.

The UPC is an entirely new common patents court for the litigation of EP(UPs) and any EP validated in R-MS that have not been opted-out. The UPC’s will have jurisdiction over (i) infringement and related defences and licences; (ii) declarations of non-infringement; (iii) protective measures and injunctions; (iv) damages; (v) revocation and counterclaims for revocation; and (vi) compensation for licences of right. With the geographical reach of the UPC, pan-UPC injunctions could be extremely powerful tools for patentees. Equally, a patent under its jurisdiction can be revoked in a single action. This could be particularly attractive to a potential defendant who has missed the EPO opposition period.

The UPC will be located in local and regional courts located across the R-MS. The Central Division will be located in Paris and Munich, with the Registry and Court of Appeal located in Luxembourg. Arbitration will also be available.

As this is such a significant change to the patent litigation system, there is a transitional period of at least 7 years where future or granted EPs can be “opted-out” of the jurisdiction of the UPC. The decision as to whether or not to opt-out of the UPC system should be considered now to take advantage of the expected three-month Sunrise Period ahead of launch of the UPC. To avoid litigation in the UPC, opt-outs must be entered in the Opt-Out Register by the patent proprietor. This is not simply just looking at the proprietor listed on the register. To ensure the application to opt-out is made validly, patentees will need to consider who is entitled to be the patent proprietor. Where a patent has been assigned or licensed or is co-owned, it will be necessary to analyse who the correct decision-maker(s) is/are. The Register will be searchable and maintained by the UPC Registry. Provided that no national litigation has been initiated, the opt-out can be withdrawn at a later date.

After decades of discussion and stalled schemes for a pan-EU patent and patent litigation system, it appears that we are on the cusp of the UPC system opening its doors. This is a significant opportunity for patentees to take advantage of a wide-reaching patent right and new patents court. The next few years will be one of transition and change as litigants engage with the UPC’s rules and procedures to develop the case law of the UPC alongside the national patents courts.

 

This article was prepared by HGF’s Partner & Head of Law Rachel Fetches.

Latest updates

The EPO Board of Appeal comments on the scope of the morality exclusion from patentability

The recent decision, T1553/22 of the Board of Appeal required the Board to consider the scope of the exclusions from patentability under Article 53(a) EPC. The invention in this case …

Read article

T 1847/22: Procedural considerations in appeal: Re-ordering of requests and the impact on admissibility

Background This case concerned EP 3 085 344 B1, which relates to a wound pad, a self-adhesive member comprising a wound pad. The patent was opposed by two opponents. During …

Read article

Regulation of NGT plants in Europe- Polish Presidency proposes an alternative solution to the Patent ban

In the latest development on the new proposed legislation for the regulation of NGT (gene-edited) plants in the EU, the Polish Presidency have proposed an amendment which removes the proposed …

Read article

T 0295/22: EPO Technical Board of Appeal relies on “bonus effect” case law to find Amgen’s patent to orally administered apremilast lacking in inventive step

This case concerned Amgen’s European patent no. 2962690 for apremilast, a drug sold under the brand name Otezla®, licensed for the treatment of e.g., psoriasis and psoriatic arthritis.  The patent …

Read article
Event - 18th March 2025

Salzburg Seminar: Pitfalls in trade mark practice - What can be protected as a trade mark?

The registration of trade marks is a central component of trade mark protection – but which signs can actually be protected? In recent years, the national trade mark offices and …

Event details

Can the Chancellor’s so-called “Europe’s Silicon Valley” really replicate the innovative activity of its namesake?

The Chancellor of the UK, Rachel Reeves, recently unveiled plans to deliver an Oxford-Cambridge growth corridor that promises to boost the UK economy by up to £78 billion by 2035.  …

Read article

UPC’s CFI (Milan) extends deadline to file defence to infringement claim to align with parallel EPO appeal proceedings

Dainese S.p.A. v. Alpinestars S.p.A. & ors. UPC_CFI_472/2024 – Milan Local Division (Perrotti, Zana, Klein, Ashley) – 15 January 2025 The Milan Local Division granted a defendant’s request for an …

Read article